Bahceci, Erkut External Entity

Publications

Sort by

Selected publications

  • Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.  The Lancet. Oncology2017 Academic Article GET IT

Other